ArticleBMJ open respiratory research2026

Efficacy and safety of as-needed albuterol-budesonide versus albuterol in patients with asthma aged 12 to <18 years: design of the randomised, double-blind, parallel-group phase IIIb ACADIA trial.

Leonard Benjamin Bacharier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.